Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Somatic Cancer Mutation Panel by NGS is 14 days.

What are the prerequisites for the test Somatic Cancer Mutation Panel by NGS

  • Patient must have a confirmed diagnosis of cancer
  • Tumor sample (FFPE or frozen tissue) must be provided
  • Requisition form must be completed with relevant clinical information
  • Valid informed consent must be obtained from the patient
  • Insurance information must be provided for billing purposes

What are the measure values for the test Somatic Cancer Mutation Panel by NGS

  • Gene mutations
  • Copy number variations
  • Insertions and deletions
  • Structural rearrangements
  • Single nucleotide polymorphisms (SNPs)

What does this test Somatic Cancer Mutation Panel by NGS identify?

  • Single nucleotide variants (SNVs): This panel can detect point mutations in the DNA sequence that may be associated with cancer development.
  • Insertions and deletions (Indels): The panel can also identify small insertions or deletions in the DNA that may play a role in cancer progression.
  • Copy number variations (CNVs): This test can identify changes in the number of copies of specific regions of the DNA, which may be indicative of cancer.
  • Rearrangements: The panel can detect structural rearrangements in the DNA, such as translocations or inversions, that may be involved in cancer development.

Why is this test Somatic Cancer Mutation Panel by NGS taken?

  • Identification of Mutations: The Somatic Cancer Mutation Panel by NGS is taken to identify genetic mutations in cancer cells. These mutations can help in understanding the underlying causes of cancer and may guide treatment decisions.
  • Personalized Treatment: By analyzing the mutations present in a patient's tumor, doctors can tailor treatment plans to target specific genetic abnormalities. This personalized approach can lead to more effective therapies and better outcomes for patients.
  • Monitoring Disease Progression: Regular testing with the Somatic Cancer Mutation Panel can help track changes in a patient's tumor over time. This information can be used to monitor disease progression, evaluate treatment effectiveness, and make adjustments to therapy as needed.
  • Prognostic Information: Certain mutations detected by the panel may provide prognostic information about the aggressiveness of the cancer or the likelihood of recurrence. This information can help guide treatment decisions and follow-up care.

No FAQs available.

Customer Google Rating